Product Information
BUSPIRONE HCL 7.5 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.1105 per EA under NDC 64380078706. Its NADAC has been published 472 times since Jun 14, 2017.
Strength
7.5 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380078706
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202330On Market Since
2/17/2017
Price Statistics
The NADAC for BUSPIRONE HCL 7.5 MG TABLET has been published 472 times since Jun 14, 2017, and over the history we have for it it has declined 75.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1105 per EA |
|---|---|
| All-time high | $0.5601 (Mar 14, 2018) |
| All-time low | $0.0797 (Nov 20, 2024) |
| 52-week high | $0.1225 |
| 52-week low | $0.1105 |
| Median price | $0.2204 |
| Average price | $0.2604 |
| Largest weekly change | -42.2% (Nov 20, 2024) |
| Weeks tracked | 472 |
| Tracking since | Jun 14, 2017 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 7.5 MG TABLET, manufactured by Strides Pharma Inc., is $0.1105 per EA (NDC 64380078706), effective Jun 24, 2026.
How has the price of BUSPIRONE HCL 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has declined 75.4%. It has been tracked across 472 weekly CMS publications since Jun 14, 2017.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 7.5 MG TABLET?
Since Jun 14, 2017, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has ranged from a low of $0.0797 (Nov 20, 2024) to a high of $0.5601 (Mar 14, 2018), with a median of $0.2204 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 7.5 MG TABLET?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BUSPIRONE HCL 7.5 MG TABLET, is $0.1039 per EA — about 6% below BUSPIRONE HCL 7.5 MG TABLET.
Who manufactures BUSPIRONE HCL 7.5 MG TABLET?
BUSPIRONE HCL 7.5 MG TABLET (NDC 64380078706) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification